Rankings
▼
Calendar
URGN FY 2015 Earnings — UroGen Pharma Ltd. Revenue & Financial Results | Market Cap Arena
URGN
UroGen Pharma Ltd.
$918M
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$113,000
Operating Income
-$12M
Net Income
-$13M
EPS (Diluted)
$-5.51
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$449,000
Balance Sheet
Total Assets
$19M
Total Liabilities
$2M
Stockholders' Equity
$17M
Cash & Equivalents
$18M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$113,000
$0
—
Operating Income
-$12M
-$4M
-184.0%
Net Income
-$13M
-$5M
-178.5%
← FY 2014
All Quarters
Q1 2016 →